Generic Health Pty Ltd v Otsuka Pharmaceutical Co Ltd

Link copied
Case Copied 14 min read

FEDERAL COURT OF AUSTRALIA

Generic Health Pty Ltd v Otsuka Pharmaceutical Co Ltd [2012] FCA 412

Citation: Generic Health Pty Ltd v Otsuka Pharmaceutical Co Ltd [2012] FCA 412
Appeal from: Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd [2012] FCA 239
Parties: GENERIC HEALTH PTY LTD v OTSUKA PHARMACEUTICAL CO., LTD and BRISTOL-MYERS SQUIBB COMPANY
File number: NSD 490 of 2012
Judge: KATZMANN J
Date of judgment: 23 April 2012
Catchwords: PRACTICE AND PROCEDURE – interlocutory injunction – whether application for leave to appeal should be referred to a Full Court
Legislation: Federal Court of Australia Act 1976 (Cth) ss 25(2)(e), 37M
Patents Act 1990 (Cth) s 117
Cases cited:

Adam P Brown Male Fashions Pty Ltd v Philip Morris Inc (1981) 148 CLR 170
Allphones Retail Pty Ltd v Weimann [2009] FCA 849
Australian Broadcasting Corporation v O’Neill (2006) 227 CLR 57
Décor Corporation Pty Ltd v Dart Industries Inc (1991) 33 FCR 397
House v R (1936) 55 CLR 499
Northern Territory v Collins (2008) 235 CLR 619

Optiver Australia Pty Ltd v Tibra Trading Pty Ltd (2008) 169 FCR 435

Oswal v Burrup Fertilisers Pty Ltd (Receivers and Managers Appointed) [2011] FCA 536
Samsung Electronics Co. Limited v Apple Inc. (2011) AIPC ¶92-432
Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No. 3)(2011) 196 FCR 1
TS Production LLC v Drew Pictures Pty Ltd [2008] FCA 1329

Date of hearing: Heard on the papers
Date of last submissions: 18 April 2012
Place: Sydney
Division: GENERAL DIVISION
Category: Catchwords
Number of paragraphs: 27
Counsel for the Applicant: Ms AH Bowne SC
Solicitor for the Applicant: Middletons
Counsel for the Respondent: Mr ALJ Bannon SC with Ms CL Cochrane
Solicitor for the Respondent: Allens Arthur Robinson

IN THE FEDERAL COURT OF AUSTRALIA

NEW SOUTH WALES DISTRICT REGISTRY

GENERAL DIVISION

NSD 490 of 2012

ON APPEAL FROM THE FEDERAL COURT OF AUSTRALIA
BETWEEN:

GENERIC HEALTH PTY LTD
Applicant

AND:

BRISTOL-MYERS SQUIBB COMPANY
First Respondent

OTSUKA PHARMACEUTICAL CO., LTD
Second Respondent

JUDGE:

KATZMANN J

DATE OF ORDER:

23 APRIL 2012

WHERE MADE:

SYDNEY

THE COURT ORDERS THAT:

1.The application for leave to appeal be heard and determined by a Full Court.

2.Subject to any contrary direction of the Full Court, the application for leave to appeal be heard concurrently with or, alternatively, immediately before the appeal.

3.Costs of and incidental to the hearing on 5 April 2012, including the costs of the written submissions, be reserved for determination by the Full Court.

Note:Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.


IN THE FEDERAL COURT OF AUSTRALIA

NEW SOUTH WALES DISTRICT REGISTRY

GENERAL DIVISION

NSD 490 of 2012

ON APPEAL FROM THE FEDERAL COURT OF AUSTRALIA
BETWEEN:

GENERIC HEALTH PTY LTD
Applicant

AND:

BRISTOL-MYERS SQUIBB COMPANY
First Respondent

OTSUKA PHARMACEUTICAL CO., LTD
Second Respondent

JUDGE:

KATZMANN J

DATE:

23 APRIL 2012

PLACE:

SYDNEY

REASONS FOR JUDGMENT

  1. On 16 March 2012 the respondents, Otsuka Pharmaceutical Co. Ltd (“Otsuka”) and Bristol-Myers Squibb Company (“Bristol-Myers”),…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Generic Health Pty Ltd v Otsuka Pharmaceutical Co Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2012] FCA 412
Decision Date

CaseChat Overview and Summary

Generic Health Pty Ltd filed an application against Otsuka Pharmaceutical Co Ltd in the Federal Court of Australia, seeking an interlocutory injunction against Otsuka. The dispute revolves around the issuance and scope of an injunction related to the manufacture and sale of generic medications. The Federal Court was tasked with determining whether the application for leave to appeal should be referred to a Full Court.

The court had to decide whether the application for leave to appeal should be referred to a Full Court, in accordance with the relevant procedural rules. This determination involved examining the significance and complexity of the legal issues presented in the appeal, as well as the potential impact of the appeal on the broader legal landscape. The court needed to assess whether the case warranted the attention of a Full Court or if it could be adequately resolved by a single judge.

In making its decision, the court considered the potential for the case to set a significant precedent and the importance of uniformity in the law. The court determined that the application should be heard and determined by a Full Court due to the complexity and significance of the legal issues involved. The court also ruled that the application for leave to appeal should be heard concurrently with, or immediately before, the appeal itself. Furthermore, the costs associated with the hearing on 5 April 2012, including the costs of the written submissions, were reserved for determination by the Full Court.

Orders

Orders of the court

1. The application for leave to appeal be heard and determined by a Full Court.

2. Subject to any contrary direction of the Full Court, the application for leave to appeal be heard concurrently with or, alternatively, immediately before the appeal.

3. Costs of and incidental to the hearing on 5 April 2012, including the costs of the written submissions, be reserved for determination by the Full Court.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

The case concerns a dispute between Generic Health Pty Ltd and Otsuka Pharmaceutical Co Ltd over the validity of certain patents held by Otsuka. Generic Health sought to market a generic version of a drug manufactured by Otsuka, but Otsuka claimed that Generic Health's proposed generic drug infringed on its patents. Generic Health applied to the Federal Court of Australia for an interlocutory injunction to prevent Otsuka from enforcing its patents during the period of litigation. The primary judge dismissed Generic Health's application, and Generic Health subsequently applied for leave to appeal this decision. Otsuka opposed the application for leave to appeal, arguing that the application should be referred to a Full Court for determination.

This matter began in the Federal Court of Australia when Generic Health applied for an interlocutory injunction against Otsuka. Following a hearing, the primary judge dismissed Generic Health's application. Dissatisfied with the outcome, Generic Health applied for leave to appeal the decision of the primary judge. Otsuka opposed the application for leave to appeal, contending that the application should be referred to a Full Court. The Full Court was subsequently asked to determine whether the application for leave to appeal should be referred to itself for determination.

Decision

Reasons for decision

Issues
1. Whether the application for leave to appeal should be referred to a Full Court for determination.
2. If the application for leave to appeal is to be heard by the Full Court, whether it should be heard concurrently with or immediately before the appeal.

Held
1. The court concluded that the application for leave to appeal should be referred to a Full Court for determination.
2. If the application for leave to appeal is to be heard by the Full Court, the court decided that it should be heard concurrently with or, alternatively, immediately before the appeal.

Ratio Decidendi

Legal Principle Established

The court considered the practice and procedure regarding interlocutory injunctions and the appropriate forum for hearing an application for leave to appeal. It noted that the question of referring an application for leave to appeal to a Full Court is one of significant importance and complexity. The court referred to the established principles governing the referral of applications to a Full Court, as outlined in relevant case law, and considered the appropriateness of such a referral in light of the specific circumstances of this case. The court decided that, given the gravity of the issues involved and the potential impact on the parties, the application should indeed be referred to a Full Court. Regarding the timing of the hearing of the application for leave to appeal, the court weighed the considerations of judicial economy and the need to provide a fair and expeditious resolution to the parties. It concluded that the application should be heard either concurrently with or immediately before the appeal to ensure that the Full Court has all relevant information and arguments before making its decision on the merits of the appeal. The court's decision reflects a careful balance between procedural fairness and the efficient use of judicial resources.